Glaukos Q3 2024 Earnings Report
Key Takeaways
Glaukos Corporation reported record net sales of $96.7 million for the third quarter of 2024, a 24% increase year-over-year. The company's glaucoma sales reached $76.0 million, up 30% year-over-year, while corneal health sales increased by 5% to $20.6 million. The company raised its 2024 net sales guidance to $377 million to $379 million.
Record net sales of $96.7 million, a 24% increase year-over-year.
Glaucoma net sales reached a record $76.0 million, up 30% year-over-year.
Corneal Health net sales increased by 5% year-over-year to $20.6 million.
2024 net sales guidance raised to $377 million - $379 million.
Glaukos
Glaukos
Glaukos Revenue by Segment
Forward Guidance
The company expects 2024 net sales to be in the range of $377 million to $379 million based on the latest foreign currency exchange rates.
Revenue & Expenses
Visualization of income flow from segment revenue to net income